Moods Disorders Completed Phase 3 Trials for Sertraline (DB01104)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01360866Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)Treatment